This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hirose, M. Articles by Ito, N. Search for Related Content PubMed PubMed Citation Articles by Hirose, M. Articles by Ito, N.

Reversibility of Catechol-induced Rat Glandular Stomach Lesions¹

First Department of Pathology, Nagoya City University Medical School, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467, Japan

The potential reversibility of glandular stomach lesions induced by the clastogen, catechol, was examined in groups of male F344 rats treated continuously with 0.8% catechol in the diet for 12, 24, 48, 72, or 96 weeks. After a return to basal diet for 84, 72, 48, 24, and 0 weeks, respectively, the animals were killed for histopathological examination. Incidences of submucosal hyperplasia, adenomas and adenocarcinomas, average number of tumors per rat, and the size of tumors in rats treated with catechol for 12, 24, 48, 72, and 96 weeks increased time dependently. After cessation of catechol treatment, although average number of tumors per rat slightly decreased, the size of tumors tended to increase. Labeling indices in both tumorous and nontumorous areas decreased after cessation of catechol treatment. The results thus indicate that whereas some submucosal hyperplasias or adenomas may regress, others have the potential to develop into adenomas or adenocarcinomas. However, tumor growth does depend to a certain extert on continued catechol treatment.

¹ This work was supported by a Grant-in-Aid for Cancer Research from the Ministry of Education, Science and Culture, Japan; a grant from the Ministry of Health and Welfare, Japan; a grant from the Society for Promotion of Pathology of Nagoya, Japan; and a grant from the Experimental Pathological Research Association, Japan.

² To whom requests for reprints should be addressed.

Received 1/17/91. Accepted 12/ 3/91.

This article has been cited by other articles:

				A. Hagiwara, Y. Takesada, H. Tanaka, S. Tamano, M. Hirose, N. Ito, and T. Shirai Dose-dependent Induction of Glandular Stomach Preneoplastic and Neoplastic Lesions in Male F344 Rats Treated with Catechol Chronically Toxicol Pathol, February 1, 2001; 29(2): 180 - 186. [Abstract] [PDF]

				S. K. Manna and B. B. Aggarwal Differential Requirement for p56lck in HIV-tat Versus TNF-Induced Cellular Responses: Effects on NF-{kappa}B, Activator Protein-1, c-Jun N-Terminal Kinase, and Apoptosis J. Immunol., May 15, 2000; 164(10): 5156 - 5166. [Abstract] [Full Text] [PDF]

				M. Hirose, K. Hakoi, S. Takahashi, T. Hoshiya, K. Akagi, Cuilin, K. Saito, H. Kaneko, and T. Shirai Sequential Morphological and Biological Changes in the Glandular Stomach Induced by Oral Administration of Catechol to Male F344 Rats Toxicol Pathol, July 1, 1999; 27(4): 448 - 455. [Abstract] [PDF]

				A. Kumar, S. K. Manna, S. Dhawan, and B. B. Aggarwal HIV-Tat Protein Activates c-Jun N-Terminal Kinase and Activator Protein-1 J. Immunol., July 15, 1998; 161(2): 776 - 781. [Abstract] [Full Text] [PDF]